Results 101 to 110 of about 29,458 (191)

Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial [PDF]

open access: yes, 2014
Background Vancomycin is the standard first-line treatment for methicillin-resistant Staphylococcus aureus bacteremia. However, recent consensus guidelines recommend that clinicians consider using alternative agents such as daptomycin when the vancomycin
David Lye   +7 more
core   +4 more sources

Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.

open access: yesPLoS ONE
BackgroundIn the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs), vancomycin stands as the prevalent therapeutic agent.
Yau Adamu   +3 more
doaj   +1 more source

Identification of a novel ltaS mutation in daptomycin heteroresistant community-acquired methicillin-resistant Staphylococcus aureus ST72 strains in South Korea

open access: yesInternational Journal of Infectious Diseases
Daptomycin has been used globally since 2003, with a corresponding increase in daptomycin nonsusceptible (DNS) Staphylococcus aureus. In South Korea, daptomycin became available in 2020, but emerging resistance has posed early therapeutic challenges.
Sun Hee Park   +3 more
doaj   +1 more source

De Novo Daptomycin-Nonsusceptible Enterococcal Infections

open access: yesEmerging Infectious Diseases, 2012
Potential emergence of enterococcal daptomycin nonsusceptibility among patients with no prior exposure to daptomycin poses clinical and public health challenges.
Theodoros Kelesidis   +3 more
doaj   +1 more source

Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification

open access: yesBMC Pharmacology and Toxicology, 2017
Background Several studies have reported that daptomycin induced artificial prolongation of prothrombin time (PT) in some test reagents, particularly in warfarin users.
Hideki Hashimoto   +5 more
doaj   +1 more source

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?

open access: yesInfectious Diseases and Therapy, 2019
Introduction Previous series on the use of daptomycin in enterococcal infective endocarditis (EIE) have shown various outcomes, including higher mortality rates. We analyzed the effectiveness of high-dose daptomycin for the treatment of EIE.
Maddalena Peghin   +5 more
doaj   +1 more source

Comparative Activity of Daptomycin and Teicoplanin against Enterococci Isolated from Blood and Urine

open access: yesCanadian Journal of Infectious Diseases, 1992
The authors compared the activity of daptomycin with that of ampicillin, penicillin, teicoplanin and vancomycin against 304 strains of Enterococcus species isolated from blood and urine.
Kevin R Forward   +3 more
doaj   +1 more source

Evaluating Prescriber Adherence to Guideline-Based Treatment Pathways of a Newly Initiated Antimicrobial Stewardship Program at a Rehabilitation Hospital [PDF]

open access: yes, 2017
Background: Inappropriate use of antimicrobials in the healthcare setting is associated with consequences including antimicrobial resistance, Clostridium difficile infection (CDI), adverse drug reactions, and increased healthcare costs.
Bertram, Christie
core   +1 more source

The Nephrotoxicity of Vancomycin. [PDF]

open access: yes, 2017
Farber, John L.   +2 more
core   +2 more sources

Empiric antibiotics for sepsis [PDF]

open access: yes, 2018
Buckman, Sara A   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy